Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: BNTX

Group By Ticker
Sort By
Newest | Oldest
Read More
5 minute read
  • Biotech
  • FDA
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact

By Shanthi Rexaline
June 4, 9:39 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3)

ALLO

Read More
1 minute read
  • Eurozone
  • FDA
  • Markets
  • News

UPDATE: UK’s Medicines and Healthcare products Regulatory Agency Says Data For Neutralizing Antibodies Of Pfizer/BioNTech’s COVID-19 Vaccine Work At Same Levels As Seen In Adults Aged 16-25 Years

By Benzinga Newsdesk
June 4, 6:06 AM
-Reuters

BNTX

Read More
1 minute read
  • Eurozone
  • FDA
  • Markets
  • News

UK’s Medicines and Healthcare products Regulatory Agency Concludes Positive Safety Profile For Pfizer/BioNTech’s COVID-19 Vaccine In 12-to-15 Year Olds

By Benzinga Newsdesk
June 4, 6:03 AM
-Reuters-Reuters

BNTX

Read More
1 minute read
  • General
  • News
  • Politics
  • Rumors

White House Says Will Allocate ~19M COVID-19 Vaccine Doses To Be Shared Through Covax

By Benzinga Newsdesk
June 3, 11:15 AM
-Reuters

AZN

Read More
7 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Trading Ideas

Stocks That Hit 52-Week Highs On Thursday

By Benzinga Insights
June 3, 10:12 AM
    Before 10 a.m. ET on Thursday, 86 companies set new 52-week highs.

AAT

Read More
5 minute read
  • Biotech
  • FDA
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout

By Shanthi Rexaline
June 3, 8:23 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2)

AMYT

Read More
2 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • News

Myocarditis Cases Probably Linked to Pfizer COVID-19 Vaccine, Says Israel Health Ministry: Reuters

By Vandana Singh
June 2, 2:28 PM
Israel’s Health Ministry has reportedly found the small number of heart inflammation cases, observed mainly in young men who…

BNTX

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

US NIH Initiates Trial to Assess Mix-Match of COVID-19 Vaccine Booster Shots: CNBC

By Vandana Singh
June 2, 2:20 PM
The National Institutes of Health (NIH) has started an early-stage clinical trial to assess what happens when a…

BNTX

Read More
2 minute read
  • Eurozone
  • FDA
  • Markets
  • News

Pfizer and BioNTech Confirm First Authorization in European Union for COVID-19 Vaccine in Adolescents

By Charles Gross
May 28, 3:46 PM
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Conditional Marketing Authorization (CMA) for COMIRNATY® in the European Union (EU) has been expanded to include individuals 12 to 15 years of age.

BNTX

Read More
1 minute read
  • General
  • Health Care

CDC Says 166,388,129 Individuals Have Received At Least One Dose Of COVID-19 Vaccine As Of May 28

By Bill Haddad
May 28, 2:39 PM
-Reuters

BNTX

Posts navigation

Previous 1 … 85 86 87 … 92 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service